Priority Date: 27.07.12 (NZ 20120601512)

METHOD OF TREATING OPTIC NERVE DAMAGE, OPHTHALMIC ISCHEMIA OR OPHTHALMIC REPERFUSION INJURY

  • Application ID: EP13822996
  • Status: EXAMINATION IN PROGRESS

Attorney

operating since 1890
Headquarter in London and 4 offices
active in Legal Services

Specialization

This patent has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) Mewburn Ellis LLP is specialized in A61. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 27.07.2012 - Priority Date (NZ 20120601512)
  • 30.01.2014 - Publication A1 (WO2014017927)
  • 03.06.2015 - Publication A1 (EP2877195)

IPC Classification